Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies — StellaEarly Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(1 site)
China
The Obstetrics and Gynecology Hospital of Fudan University, Shanghai, Shanghai Municipality Age range
18 Years – 75 Years
Last updated February 2026